Description

Nifuroxazid-Sperco (Nifuroxazide) Capsules 200 mg. №12

Ingredients

Each capsule contains 200 mg of Nifuroxazide.

Dosage

The recommended dosage for adults is one capsule three times a day. It is important to follow the instructions provided by your healthcare provider.

Indications

Nifuroxazide is indicated for the treatment of acute infectious diarrhea. It works by stopping the growth of bacteria causing the infection.

Contraindications

Do not use Nifuroxazide if you are allergic to the active ingredient or any other ingredients in the product. Consult your doctor before taking this medication if you are pregnant, breastfeeding, or have any underlying medical conditions.

Directions

Swallow the capsules whole with a full glass of water. It is best to take the medication with food to reduce the risk of stomach upset.

Scientific Evidence

Nifuroxazide has been extensively studied for its efficacy in treating acute infectious diarrhea. Research published in the International Journal of Antimicrobial Agents has shown that Nifuroxazide is effective in reducing the duration and severity of diarrhea symptoms. The mechanism of action involves targeting the bacterial pathogens in the gut without affecting the normal flora, making it a targeted and efficient treatment option.

Additional Information

It is important to complete the full course of treatment with Nifuroxazide as prescribed by your healthcare provider, even if you start to feel better before the medication is finished. This helps prevent the recurrence of the infection and ensures complete recovery. If you experience any severe side effects or allergic reactions, seek medical attention immediately.

Pharmacological Effects: Nifuroxazide works by inhibiting the synthesis of bacterial proteins, thereby stopping the growth and multiplication of the bacteria causing diarrhea. It acts locally in the gastrointestinal tract, reducing the symptoms of diarrhea without significant systemic absorption.

Clinical Trials: Clinical trials have demonstrated the efficacy of Nifuroxazide in reducing the duration and frequency of diarrhea episodes compared to a placebo. The drug has shown a favorable safety profile with minimal side effects, making it a well-tolerated option for the treatment of infectious diarrhea.